Victoria Woodcock
7PUBLICATIONS
48CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Apr 24, 2025
CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade.Gusztav Milotay, Martin Little, Robert A Watson
|Apr 24, 2024
Publisher Correction: Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells.Mike B Barnkob, Yale S Michaels, Violaine André
|Apr 12, 2024
Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells.Mike B Barnkob, Yale S Michaels, Violaine André
|Apr 07, 2023
PemBla: A Phase 1 study of intravesical pembrolizumab in recurrent non-muscle-invasive bladder cancer.Victoria K Woodcock, Ji-Li Chen, Karin Purshouse
|Dec 16, 2022
IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma.Chelsea A Taylor, Robert A Watson, Orion Tong
Pageof 2
Frequent Collaborators
3 joint publications
Mark R Middleton
3 joint publications
Benjamin P Fairfax
2 joint publications
Margarida Rei
2 joint publications
Orion Tong
2 joint publications
Philip S Macklin
2 joint publications
James J Gilchrist
2 joint publications
Salvatore Valvo
2 joint publications
Uzi Gileadi
2 joint publications
Yale S Michaels
2 joint publications
Mike B Barnkob
